Research Papers:
Inhibitory effect of caveolin-1 in vascular endothelial cells, pericytes and smooth muscle cells
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1875 views | HTML 2872 views | ?
Abstract
Hongping Xu1, Liwei Zhang1, Wei Chen1, Jiazhou Xu1, Ruting Zhang1, Ran Liu1, Lan Zhou1, Wenjie Hu1, Rong Ju1, Chunsik Lee1, Weisi Lu1, Anil Kumar1, Xuri Li1 and Zhongshu Tang1
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, P. R. China
Correspondence to:
Zhongshu Tang, email: [email protected]
Xuri Li, email: [email protected]
Keywords: caveolin-1, cavtratin, endothelial cell, pericyte, smooth muscle cell
Received: December 27, 2016 Accepted: June 19, 2017 Published: July 12, 2017
ABSTRACT
Caveolin-1 (Cav1) is the principle structural protein of caveolae. It plays important roles in the vascular system under both physiological and pathological conditions. Although Cav1 has been shown to inhibit microvascular permeability and has been considered as a tumor-suppressor for years, the underlying cellular mechanism has yet to be discovered. Here, we systematically investigated Cav1 functions in the main types of vascular cells, including endothelial cells (ECs), pericytes (PCs) and smooth muscle cells (SMCs). We synthesized a cell-permeable peptide called cavtratin that is derived from the Cav1 scaffolding domain. We found that cavtratin inhibited ECs in all assays, including survival, proliferation, migration and permeability assays. It also inhibited the proliferation of PCs and SMCs but had no effect on their survival or migration. The inhibitory effect of cavtratin on the proliferation of all vascular cells suggests that Cav1 plays important roles in vascular development and angiogenesis. Under physiological condition, the main function of Cav1 is to inhibit EC permeability.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19191